M
Manon Nayrac
Researcher at Université de Montréal
Publications - 8
Citations - 405
Manon Nayrac is an academic researcher from Université de Montréal. The author has contributed to research in topics: Antibody & Immunity. The author has an hindex of 5, co-authored 8 publications receiving 130 citations.
Papers
More filters
Journal ArticleDOI
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses.
Alexandra Tauzin,Manon Nayrac,Mehdi Benlarbi,Shang Yu Gong,Romain Gasser,Guillaume Beaudoin-Bussières,Nathalie Brassard,Annemarie Laumaea,Dani Vézina,Jérémie Prévost,Sai Priya Anand,Catherine Bourassa,Gabrielle Gendron-Lepage,Halima Medjahed,Guillaume Goyette,Julia Niessl,Olivier Tastet,Laurie Gokool,Chantal Morrisseau,Pascale Arlotto,Leonidas Stamatatos,Leonidas Stamatatos,Andrew T. McGuire,Catherine Larochelle,Pradeep D. Uchil,Maolin Lu,Walther Mothes,Gaston De Serres,Sandrine Moreira,Michel Roger,Jonathan Richard,Valérie Martel-Laferrière,Ralf Duerr,Cécile Tremblay,Daniel Kaufmann,Andrés Finzi,Andrés Finzi +36 more
TL;DR: In this article, a single dose of the BNT162b2 mRNA vaccine for SARS-CoV-2 was found to be up to 90% effective starting 14 days post-administration.
Journal ArticleDOI
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset.
Sai Priya Anand,Jérémie Prévost,Manon Nayrac,Guillaume Beaudoin-Bussières,Mehdi Benlarbi,Romain Gasser,Nathalie Brassard,Annemarie Laumaea,Shang Yu Gong,Catherine Bourassa,Elsa Brunet-Ratnasingham,Halima Medjahed,Gabrielle Gendron-Lepage,Guillaume Goyette,Laurie Gokool,Chantal Morrisseau,Philippe Bégin,Valérie Martel-Laferrière,Cécile Tremblay,Jonathan Richard,Renée Bazin,Ralf Duerr,Daniel Kaufmann,Andrés Finzi,Andrés Finzi +24 more
TL;DR: In this article, the presence of SARS-CoV-2-specific memory B cells in convalescent individuals was evaluated using a longitudinal assessment of humoral immune responses.
Posted ContentDOI
Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
Sai Priya Anand,Jérémie Prévost,Manon Nayrac,Guillaume Beaudoin-Bussières,Mehdi Benlarbi,Romain Gasser,Nathalie Brassard,Annemarie Laumaea,Shang Yu Gong,Catherine Bourassa,Elsa Brunet-Ratnasingham,Halima Medjahed,Gabrielle Gendron-Lepage,Guillaume Goyette,Laurie Gokool,Chantal Morrisseau,Philippe Bégin,Valérie Martel-Laferrière,Cécile Tremblay,Jonathan Richard,Renée Bazin,Ralf Duerr,Daniel Kaufmann,Andrés Finzi,Andrés Finzi +24 more
TL;DR: In this article, the evolution of the overall humoral immune responses on 101 blood samples obtained from 32 COVID-19 convalescent patients between 16 and 233 days post-symptom onset was investigated.
Posted ContentDOI
A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses
Alexandra Tauzin,Manon Nayrac,Mehdi Benlarbi,Shang Yu Gong,Romain Gasser,Guillaume Beaudoin-Bussières,Nathalie Brassard,Annemarie Laumaea,Dani Vézina,Jérémie Prévost,Sai Priya Anand,Catherine Bourassa,Gabrielle Gendron-Lepage,Halima Medjahed,Guillaume Goyette,Julia Niessl,Olivier Tastet,Laurie Gokool,Chantal Morrisseau,Pascale Arlotto,Leonidas Stamatatos,Leonidas Stamatatos,Andrew T. McGuire,Catherine Larochelle,Pradeep D. Uchil,Maolin Lu,Walther Mothes,Gaston De Serres,Sandrine Moreira,Michel Roger,Jonathan Richard,Valérie Martel-Laferrière,Ralf Duerr,Cécile Tremblay,Daniel Kaufmann,Andrés Finzi,Andrés Finzi +36 more
TL;DR: In this article, a single dose of the BNT162b2 mRNA vaccine to individuals previously infected by SARS-CoV-2 boosted all humoral and T cell responses measured, with strong correlations between T helper and antibody immunity.
Posted ContentDOI
Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality
Elsa Brunet-Ratnasingham,Sai Priya Anand,Sai Priya Anand,Pierre Gantner,Gaël Moquin-Beaudry,Alina Dyachenko,Nathalie Brassard,Guillaume Beaudoin-Bussières,Amélie Pagliuzza,Romain Gasser,Mehdi Benlarbi,Floriane Point,Jérémie Prévost,Annemarie Laumaea,Julia Nießl,Manon Nayrac,Gérémy Sannier,Marianne Boutin,Jade Descôteaux-Dinelle,Gabrielle Gendron,Catherine Orban,Guillaume Butler-Laporte,Guillaume Butler-Laporte,David R. Morrison,Sirui Zhou,Sirui Zhou,Tomoko Nakanishi,Laetitia Laurent,Jonathan Richard,Mathieu Dubé,Rémi Fromentin,Rose-Marie Rébillard,Nathalie Arbour,Alexandre Prat,Catherine Larochelle,Madeleine Durand,Brent Richards,Michaël Chassé,Martine Tétreault,Nicolas Chomont,Andrés Finzi,Daniel Kaufmann +41 more
TL;DR: In this paper, the authors performed an immunovirological assessment (SARS-CoV-2 viral RNA, cytokines and tissue injury markers, antibody responses) on plasma samples collected from 144 hospitalised COVID-19 patients 11 days after symptom onset and used to test models predicting mortality within 60 days of symptom onset.